Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
The U.S. International Trade Commission issued a ban preventing Apple from importing all watches that use heart monitoring technology at the heart of a battle with AliveCor. But the ban will be suspended until appeals over the patents in question have played out. → Read More
Medicare’s hospital at home program may soon get a lifeline from Congress. Can it prove its worth? → Read More
Virtual reality startups BehaVR and OxfordVR have merged and raised new funding as they look to develop treatments for anxiety and chronic pain. → Read More
In a significant victory, Apple has successfully challenged patents at the center of a high-profile dispute with medical device company AliveCor. → Read More
Google Cloud has honed its message for hospital systems wary of moving their data to its services: We are going to make this very easy for you. → Read More
In the latest edition of STAT Health Tech: Amazon launches a new health venture, Google tests search in health care, & Maven’s raises a $90 million round. → Read More
Silicon Valley venture capital giant a16z has struck a surprising new partnership with a rural health system in upstate New York. Here's what's in it for both of them. → Read More
Following a year of executive shakeups and business rejiggering, Talkspace’s third quarter earnings came with some good news. → Read More
A large insurer’s decision to cover FDA-cleared prescription digital therapeutics for psychiatric and other conditions could prove to be a landmark moment. → Read More
Alzheimer’s clinical trials have a recruitment problem. Telehealth platform Ro just struck an agreement with the National Institute on Aging to try to help. → Read More
Here's STAT's health tech tracker for the fourth quarter, featuring 17 key industry events and milestones to watch. → Read More
In the latest edition of STAT Health Tech: FDA moves on AI tools, bionic pancreas research, & equity in digital therapeutics. → Read More
Should health app makers use sham controls to test their products more rigorously? Some industry leaders say it isn't strictly necessary. → Read More
A top digital health official at the FDA said the agency's approach to reviewing updates for digital health products is too slow for companies and consumers. → Read More
Early in the pandemic, employers panic-shopped for virtual mental health services. Now, there are signs of that sales momentum slowing down. → Read More
Exclusive: Calm's head of science, who helped build an impressive evidence base for the wellness app, has left the company. The future of its research team is unclear. → Read More
As companies selling mental health apps struggle to prove their worth to a skeptical health care system, we’re about to start hearing a lot more about “engagement.” → Read More
Today, in the wake of a Supreme Court decision overturning Roe v. Wade, health data privacy is getting its own Cambridge Analytica moment. → Read More
The FDA has cleared an Apple Watch-based system to track tremors and other symptoms of Parkinson's disease. → Read More
In the latest edition of STAT Health Tech: Teladoc's Livongo losses, tech to predict no-shows, and the FDA on AI. → Read More